Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Organon & Co.

Tracked across 8 events · 131 articles · First seen May 23, 2025 · Last active Sep 08, 2026

Sentiment
19
Attention
6
Events
8
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Business
Moody s Ratings and S&P Global Ratings assigned investment-grade credit ratings to Sun Pharma Industries, India's largest pharmaceutical company, in connection with its proposed USD 11.75 billion acquisition of US-based Organon & Co. S&P assigned…
Impact: Organon is the target of Sun Pharma's acquisition. The deal is expected to close by March 2027, and Organon is projected to contribute 40-45% of the combined group's EBITDA, enhancing Sun Pharma's scale and geographic reach.
Sep 08, 2026 · 6 articles
2 20
Business
Impact: Organon shareholders approved the proposed acquisition by Sun Pharma, which is on track to close in early 2027, expected to strengthen Sun's specialty portfolio.
Jul 31, 2026 · 7 articles
6 30
Business
Impact: Organon & Co. is the target of a significant acquisition by Sun Pharma, showcasing outbound M&A from India.
May 21, 2026 · 6 articles
6 40
Domestic
On August 31, 2026, President Donald Trump announced voluntary drug pricing agreements with nine pharmaceutical companies: Alcon, Astellas Pharma, BeOne Medicines, BridgeBio Pharma, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB. These companies agreed…
Impact: Organon & Co. is the target of Sun Pharma's $11.75 billion acquisition, which is reinforced by Sun's U.S. pricing agreement and tariff relief.
Aug 18, 2026 · 37 articles
6 0
Business
Impact: Acquired by Sun Pharma in 2026; mentioned as comparable deal.
Jul 06, 2026 · 34 articles
6 0
Business
Apr 26, 2026 · 28 articles
4 0
Business
Apr 29, 2026 · 6 articles
4 0
Domestic
Apr 27, 2026 · 7 articles
Roivant Sciences buyer ↔ Organon & Co. Organon & Co. acquired Dermavant Sciences, a dermatology subsidiary, from Roivan
Roivant Sciences seller ↔ Organon & Co. Roivant Sciences divested its dermatology subsidiary, Dermavant Sciences, to Org
Sun Pharma ↔ Organon & Co.
Sun Pharma ↔ Organon & Co.
ERGEN INTELLIGENCE
Track Organon & Co. live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.